Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes: later-stage trial registry
86 of 342 indexed Diabetes trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #19 of 28,707 conditions by registered trial count.
342 US clinical trials · 86 currently recruiting · #19 of 28,707 conditions by registered trial count
Diabetes: 342 US clinical trials tracked, 86 recruiting.
Diabetes is the subject of 342 registered US clinical trials on ClinicalTrials.gov, 86 of them currently open to new participants. 55 are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 41 of these trials.
Enrollment posture brief
Registry condition diabetes
OPEN 86 | RECR 25% | LATE 55 | EARLY 36 | RANK #19 | SPON 41
Volume-matched condition peers
Nearest open-share peer: Low Back Pain (25% recruiting · 123 trials)
Diabetes lists 86 open slots (25% of 342 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes is recruiting below its size-band peers.
86 of 342 indexed trials (25.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes trials is spread across many organizations.
Novo Nordisk A/S accounts for 41 of 342 trials (12%). 161 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes enrolment sits around 150 participants.
Median target enrolment is 150 among the 339 trials that report a genuine target (sentinel values excluded). 144 of those (42.5%) plan for fewer than 100 participants.
-
Diabetes research is mostly interventional.
263 interventional and 79 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
342 total, page 1 of 7
Personalized Responses to Dietary Composition Trial 3
Zoe Global Limited
NCT04735835
Social Needs Screening and Chronic Diseases Study (WE CARE)
University of Massachusetts, Worcester
NCT06903897
The T1D Exchange Registry
T1D Exchange, United States
NCT04629586
Personalized Environment and Genes Study
National Institute of Environmental Health Sciences (NIEHS)
NCT00341237
Diabetes Clinical Decision Support
Milton S. Hershey Medical Center
NCT05447806
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
University of Michigan
NCT06104969
Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
DexCom
NCT06483945
Urinary Vitamin C Loss in Diabetic Subjects
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00071526
New Heart Imaging Techniques to Evaluate Possible Heart Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01399385
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
Texas A&M University
NCT06726590
Caregiving Networks Across Disease Context and the Life Course
National Human Genome Research Institute (NHGRI)
NCT05007990
A Natural History Study of Metabolic Sizing in Health and Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT05398783
Diabetes and Heart Disease Risk in Blacks
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00001853
Colorado Community Engagement Alliance
University of Colorado, Denver
NCT07440316
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
Massachusetts General Hospital
NCT06557005
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
iHealthScreen
NCT07151001
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Tulane University
NCT06065098
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
University of Texas Southwestern Medical Center
NCT06593314
Care Transitions App for Patients With Multiple Chronic Conditions
Brigham and Women's Hospital
NCT06051058
CHIME: Comparing Health Interventions for Maternal Equity
Stanford University
NCT06724172
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
Ohio State University
NCT06586970
Community Engagement Alliance Against Disparities
Johns Hopkins University
NCT06607341
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem
University of California, San Francisco
NCT06598436
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Brigham and Women's Hospital
NCT06569290
Capability Assessment for Diet and Activity (CADA) Model for Diabetes
University of Central Florida
NCT06631105
CARBON: UAB Cardiovascular Research Biobank
University of Alabama at Birmingham
NCT05067231
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
Johns Hopkins University
NCT05321368
Dementia and Diabetes Prevention Program
University of California, Davis
NCT04141878
Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food Boxes
Montefiore Medical Center
NCT06019624
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
University of Tennessee
NCT06374277
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
University of Wisconsin, Madison
NCT05912647
Addressing Diabetes by Elevating Access to Nutrition
Stanford University
NCT05228860
The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults
Dartmouth-Hitchcock Medical Center
NCT05824572
Increasing CGM Use Among Patients With T2D
San Diego State University
NCT06638099
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Sonavex
NCT06190717
Delta GREENS Food is Medicine Intervention
Tufts University
NCT06358859
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Endogenex
NCT06267391
Taste Bud-Derived Stem Cells in Humans
National Institute on Aging (NIA)
NCT03366168
Mechanisms Underlying Impaired Diabetic Wound Healing
University of Pittsburgh
NCT00777712
Sisters of Heart (Hermanas de Corazón): A Community Health Worker Initiative for Improving Heart Health in Migrant Farmworker Women
Emory University
NCT07111026
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
University of Colorado, Denver
NCT07011147
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
Boston Children's Hospital
NCT05464186
Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
Sutter Health
NCT06999356
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Jaeb Center for Health Research
NCT06837181
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
University of Florida
NCT05561595
Circulating Biomarkers in the Development of Type 1 Diabetes
City of Hope Medical Center
NCT05505669
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
UNC Lineberger Comprehensive Cancer Center
NCT07061652
Ultrasound Findings in Diabetic Pregnancies
Eastern Virginia Medical School
NCT06407388
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
NYU Langone Health
NCT05548205
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
Viome
NCT05465616
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 13 |
| Phase 3 | 37 |
| Phase 4 | 18 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes page
342 registered trials, 86 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 86 Diabetes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Diabetes trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes condition card totals 342 registered trials; most-linked intervention insulin degludec; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.